Ibuprofen API Global Market Analysis/Forecast Report 2024-2030: Focus on Fast-Acting and Extended-Release Formulations, Rising Global Pharmaceutical Outsourcing Creates Opportunities for Producers [Yahoo! Finance]
LowReport
Ibuprofen API Global Market Analysis/Forecast Report 2024-2030: Focus on Fast-Acting and Extended-Release Formulations, Rising Global Pharmaceutical Outsourcing Creates Opportunities for Producers [Yahoo! Finance]
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Barclays PLC. They now have a $158.00 price target on the stock, up previously from $149.00.
MediumReport
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Barclays PLC. They now have a $158.00 price target on the stock, up previously from $149.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: